Benchmark indices sensex and nifty recovered after two sessions of sharp losses, supported by gains in IT stocks and softer crude prices despite persistent foreign selling
The measure will cover branded, generic and patented non-scheduled anti-cancer drugs, with government sources estimating annual patient savings of Rs 2,500 crore
